Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO-B) Equity Ratio (2009 - 2026)

Bio-Rad Laboratories (BIO-B) reported Equity Ratio of 0.7 for Q1 2026, down 96.77% year-over-year from 21.68 in Q1 2025, and down 0.7% on a QoQ basis from 0.7 in Q4 2025.

Bio-Rad Laboratories (BIO-B) has 18 years of Equity Ratio data on file, last reported at 0.7 in Q1 2026.

  • Quarterly Equity Ratio fell 96.77% year-over-year to 0.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.7 (down 96.77% YoY) and the FY2025 annual result came in at 0.7, changed 0.45% from the prior year.
  • Equity Ratio slipped to 0.7 in Q1 2026 per BIO-B's latest filing, from 0.7 in the prior quarter.
  • Across five years, Equity Ratio topped out at 29137.33 in Q4 2023 and bottomed at 0.69 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.71 (2022), against an average of 3014.87.
  • The widest annual swing landed in 2022, when Equity Ratio jumped 24221.62%; it then slumped 100.0% in 2024.
  • Tracing BIO-B's Equity Ratio over 5 years: stood at 16025.33 in 2022, then jumped by 81.82% to 29137.33 in 2023, then tumbled by 100.0% to 0.7 in 2024, then increased by 0.45% to 0.7 in 2025, then decreased by 0.7% to 0.7 in 2026.
  • Per Business Quant, the three latest BIO-B Equity Ratio figures stand at 0.7 (Q1 2026), 0.7 (Q4 2025), and 0.69 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Bio-Rad Laboratories - - 309.40 Mn 0.70

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.70
Dec 31, 2025 0.70
Sep 30, 2025 0.69
Jun 30, 2025 0.70
Mar 31, 2025 21.68
Dec 31, 2024 0.70
Mar 31, 2024 31.03
Dec 31, 2023 29,137.33
Sep 30, 2023 0.71
Jun 30, 2023 0.71
Mar 31, 2023 0.71
Dec 31, 2022 16,025.33
Sep 30, 2022 0.70
Jun 30, 2022 0.71
Mar 31, 2022 0.71
Dec 31, 2021 65.89
Sep 30, 2021 0.77
Jun 30, 2021 0.77
Mar 31, 2021 0.76
Dec 31, 2020 24.65
Sep 30, 2020 0.73
Jun 30, 2020 0.73
Mar 31, 2020 0.72
Dec 31, 2019 0.72
Sep 30, 2019 0.71
Jun 30, 2019 0.72
Mar 31, 2019 0.71
Dec 31, 2018 0.72
Sep 30, 2018 0.73
Jun 30, 2018 0.73
Mar 31, 2018 0.72
Dec 31, 2017 0.69
Sep 30, 2017 0.68
Jun 30, 2017 0.68
Mar 31, 2017 0.68
Dec 31, 2016 0.67
Sep 30, 2016 0.67
Jun 30, 2016 0.67
Mar 31, 2016 0.68
Dec 31, 2015 0.67
Sep 30, 2015 0.66
Jun 30, 2015 0.67
Mar 31, 2015 0.66
Dec 31, 2014 0.65
Sep 30, 2014 0.64
Jun 30, 2014 0.65
Mar 31, 2014 0.65
Dec 31, 2013 0.65
Sep 30, 2013 0.65
Jun 30, 2013 0.59
Mar 31, 2013 0.59
Dec 31, 2012 0.06
Sep 30, 2012 0.59
Jun 30, 2012 0.58
Mar 31, 2012 0.58
Dec 31, 2011 0.00
Sep 30, 2011 0.57
Jun 30, 2011 0.57
Mar 31, 2011 0.55
Dec 31, 2010 0.50
Sep 30, 2010 0.53
Jun 30, 2010 0.52
Dec 31, 2009 0.50